The present invention relates to in particular immune modulatory
polypeptides and polynucleotides, recombinant materials and methods for
their production. Such polypeptides and polynucleotides are of interest
in relation to methods of treatment of diseases whereby immune responses
initiated by dendritic cells (DC), monocytes or lymphocytes, play a
causal or contributory role.
